GRAF ACQUISITION PARTNERS IV LLC (Chief Executive Officer) reported 1 transaction at NKGEN BIOTECH, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 10/4/2023ACC: 0001104659-23-106578
Officer10% Owner· Chief Executive Officer
Since May 2021
+3.47M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
5.24M acquired · 1.77M disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.77M
Price / share
—
Trade value
—
% of position
42.1%
9/29/2023
4.21M→2.44M
Total
Net shares
−1.77M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/29/2023 | J · J | −1.77M | — | — | 42.1% | 4.21M | 2.44M |
| Total | −1.77M | $0.00 | ||||||
Derivative Transactions2
Private Placement Warrants
Direct
Converts to
Common Stock
4.72M shares
Shares
+4.72M
Strike price
11.5
Held after
4.72M
Exercisable
—
9/29/2023
Working Capital Warrants
Direct
Converts to
Common Stock
523.14K shares
Shares
+523.14K
Strike price
11.5
Held after
5.24M
Exercisable
—
9/29/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Private Placement Warrants Direct | Common Stock4.72M shares | 9/29/2023 | A · Award | +4.72M | 11.5 | — | 4.72M |
| Working Capital Warrants Direct | Common Stock523.14K shares | 9/29/2023 | A · Award | +523.14K | 11.5 | — | 5.24M |